Replies to post #89870 on Biotech Values

[DewDiligence]

I hope management will shed some light on possible approval time frame at quarterly conference call.

There is nothing management can say beyond what’s already been said: MNTA and NVS have done everything that’s been requested and the ball is in the FDA’s court.

Does anyone know when that is happening?

Probably on Feb 11. Also, MNTA is presenting at the BioCEO conference on Feb 8:

http://finance.yahoo.com/news/Momenta-Pharmaceuticals-to-pz-2780709024.html?x=0&.v=1